Bill H Chang

15PUBLICATIONS
133CO-AUTHORS
Gene and molecular therapyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 20, 2026
NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

|Apr 07, 2025
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Sara K Silbert, Alexander W Rankin, Chloe N Hoang

|Feb 26, 2025
A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemia.

Basil Allen, Daniel Bottomly, Thomas Köhnke

|Aug 14, 2024
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.

Petri Pölönen, Danika Di Giacomo, Anna Eames Seffernick

|May 27, 2024
In vivo Targeting MEK and TNK2/SRC pathways in PTPN11 driven leukemia.

Bill H Chang, Karina Thiel-Klare, Jeffrey W Tyner

|Feb 10, 2024
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.

Anupam Verma, Yueh-Yun Chi, Jemily Malvar

Pageof 3

Frequent Collaborators

7 joint publications

Brian J Druker

4 joint publications

Stephen E Kurtz

4 joint publications

Christopher A Eide

4 joint publications

Jeffrey W Tyner